no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
Attenuated NYCBH vaccinia virus deleted for the E3L gene confers partial protection against lethal monkeypox virus disease in cynomolgus macaques
|
Denzler, Karen L. |
|
2011 |
29 |
52 |
p. 9684-9690 7 p. |
article |
2 |
Comparative analysis of the complete genome sequences of two Australian origin live attenuated vaccines of infectious laryngotracheitis virus
|
Lee, Sang-Won |
|
2011 |
29 |
52 |
p. 9583-9587 5 p. |
article |
3 |
Comparing pneumococcal conjugate vaccine schedules based on 3 and 2 primary doses: Systematic review and meta-analysis
|
Scott, Pippa |
|
2011 |
29 |
52 |
p. 9711-9721 11 p. |
article |
4 |
Editorial Board
|
|
|
2011 |
29 |
52 |
p. CO2- 1 p. |
article |
5 |
Establishing China's national standards of antigen content and neutralizing antibody responses for evaluation of enterovirus 71 (EV71) vaccines
|
Liang, Zhenglun |
|
2011 |
29 |
52 |
p. 9668-9674 7 p. |
article |
6 |
Financing and systems barriers to seasonal influenza vaccine delivery in community settings
|
Penfold, Robert B. |
|
2011 |
29 |
52 |
p. 9632-9639 8 p. |
article |
7 |
Foot-and-mouth disease virus particles inactivated with binary ethylenimine are efficiently internalized into cultured cells
|
Martín-Acebes, Miguel A. |
|
2011 |
29 |
52 |
p. 9655-9662 8 p. |
article |
8 |
Guillain–Barré Syndrome in India: Population-based validation of the Brighton criteria
|
Mateen, Farrah J. |
|
2011 |
29 |
52 |
p. 9697-9701 5 p. |
article |
9 |
HLA-A2-restricted survivin-derived T-cell responses
|
Straten, Per thor |
|
2011 |
29 |
52 |
p. 9582- 1 p. |
article |
10 |
Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine (PCV13) when given as a toddler dose to children immunized with PCV7 as infants
|
Grimprel, E. |
|
2011 |
29 |
52 |
p. 9675-9683 9 p. |
article |
11 |
Immunogenicity of hepatitis B vaccine among hemodialysis patients: Effect of revaccination of non-responders and duration of protection
|
Chaves, Sandra S. |
|
2011 |
29 |
52 |
p. 9618-9623 6 p. |
article |
12 |
Immunogenicity of pneumococcal conjugate vaccines in infants after two or three primary vaccinations: A systematic review and meta-analysis
|
Rückinger, Simon |
|
2011 |
29 |
52 |
p. 9600-9606 7 p. |
article |
13 |
Immunological adjuvant efficacy of glycyrrhetinic acid liposome against Newcastle disease vaccine
|
Zhao, Xiaojuan |
|
2011 |
29 |
52 |
p. 9611-9617 7 p. |
article |
14 |
Immunological Correlates of Vaccine-Derived Protection Fondation Mérieux Conference Center ‘Les Pensières’ Veyrier-Du-Lac, France, Sept. 20–22, 2010
|
Schödel, Florian |
|
2011 |
29 |
52 |
p. 9575-9577 3 p. |
article |
15 |
Methodologic reporting requirements for clinical trials
|
|
|
2011 |
29 |
52 |
p. 9578- 1 p. |
article |
16 |
Methods in vaccine effectiveness and safety studies: A critical need for vaccine confidence
|
Jacobsen, Steven J. |
|
2011 |
29 |
52 |
p. 9573-9574 2 p. |
article |
17 |
Multiple amino acid changes at the first glycosylation motif in NS1 protein of West Nile virus are necessary for complete attenuation for mouse neuroinvasiveness
|
Whiteman, Melissa C. |
|
2011 |
29 |
52 |
p. 9702-9710 9 p. |
article |
18 |
Non-adjuvanted 2009 influenza A (H1N1)v vaccine in pregnant women: The results of a French prospective descriptive study
|
Omon, E. |
|
2011 |
29 |
52 |
p. 9649-9654 6 p. |
article |
19 |
Pharmacoeconomic assessment of implementing a universal PCV-13 vaccination programme in the Valencian public health system (Spain)
|
Díez-Domingo, Javier |
|
2011 |
29 |
52 |
p. 9640-9648 9 p. |
article |
20 |
Reply to: Methodologic reporting requirements for clinical trials?
|
Poland, G.A. |
|
2011 |
29 |
52 |
p. 9579- 1 p. |
article |
21 |
Reply to Morel et al.
|
Plotkin, Stanley A |
|
2011 |
29 |
52 |
p. 9580- 1 p. |
article |
22 |
Reply to the letter by Dr. Stanley Plotkin
|
Morel, Sandra |
|
2011 |
29 |
52 |
p. 9581- 1 p. |
article |
23 |
School-based vaccination: A systematic review of process evaluations
|
Cooper Robbins, Spring Chenoa |
|
2011 |
29 |
52 |
p. 9588-9599 12 p. |
article |
24 |
The attenuated NYCBH vaccinia virus deleted for the immune evasion gene, E3L, completely protects mice against heterologous challenge with ectromelia virus
|
Denzler, Karen L. |
|
2011 |
29 |
52 |
p. 9691-9696 6 p. |
article |
25 |
The influence of the stigma of obesity on H1N1 influenza vaccine sequencing in Canada in 2009
|
Kaposy, Chris |
|
2011 |
29 |
52 |
p. 9607-9610 4 p. |
article |
26 |
Uptake of the human papillomavirus-vaccination within the free-of-charge childhood vaccination programme in Denmark
|
Widgren, Katarina |
|
2011 |
29 |
52 |
p. 9663-9667 5 p. |
article |
27 |
Vaccination by delayed treatment of infection
|
Stromberg, Sean P. |
|
2011 |
29 |
52 |
p. 9624-9631 8 p. |
article |